NFKB1 and atrial fibrillation: In this study, inhibition of ANG‐2 expression by injection of neutralizing antibodies or siRNA can down‐regulate the activity of the NF‐κB signaling pathway in vivo and in vitro and improve the ECM metabolism of AF, suggesting that ANG‐2 plays the key role in the NF‐κB signaling pathway.